| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Gufic Biosciences Limited (NSE: GUFICBIO)
GUFICBIO Technical Analysis
3
| As on 25th Apr 2024 GUFICBIO SHARE Price closed @ 320.75 and we RECOMMEND Buy for LONG-TERM with Stoploss of 284.28 & Buy for SHORT-TERM with Stoploss of 309.42 we also expect STOCK to react on Following IMPORTANT LEVELS. |
GUFICBIOSHARE Price
| Open | 315.70 | Change | Price | % |
| High | 323.45 | 1 Day | 6.30 | 2.00 |
| Low | 314.10 | 1 Week | 15.20 | 4.97 |
| Close | 320.75 | 1 Month | 23.30 | 7.83 |
| Volume | 78750 | 1 Year | 120.65 | 60.29 |
| 52 Week High 323.30 | 52 Week Low 179.95 | ||||
NSE INDIA Most Active Stocks
| IDEA | 13.90 | 6.11% |
| YESBANK | 25.95 | 1.96% |
| KOTAKBANK | 1642.45 | -10.87% |
| SOUTHBANK | 30.40 | 4.47% |
| SAIL | 164.95 | 0.18% |
| PNB | 135.90 | 2.18% |
| TATASTEEL | 167.70 | 1.30% |
| AXISBANK | 1127.00 | 6.00% |
| IRFC | 150.25 | 0.84% |
| IOB | 66.90 | 5.77% |
NSE INDIA Top Gainers Stocks
| ROML | 75.65 | 19.98% |
| POWERINDIA | 9329.50 | 13.60% |
| GPTINFRA | 211.80 | 12.51% |
| NEOGEN | 1557.75 | 12.25% |
| PNC | 65.00 | 11.02% |
| PNC | 65.00 | 11.02% |
| PNC | 65.00 | 11.02% |
| PNC | 65.00 | 11.02% |
| MOIL | 430.70 | 10.88% |
| GODFRYPHLP | 3449.70 | 10.17% |
NSE INDIA Top Losers Stocks
| GUFICBIO Daily Charts |
GUFICBIO Intraday Charts |
Whats New @ Bazaartrend |
GUFICBIO Free Analysis |
|
|
GUFICBIO Important Levels Intraday
| RESISTANCE | 338.77 |
| RESISTANCE | 332.99 |
| RESISTANCE | 329.42 |
| RESISTANCE | 325.85 |
| SUPPORT | 315.65 |
| SUPPORT | 312.08 |
| SUPPORT | 308.51 |
| SUPPORT | 302.73 |
GUFICBIO Target April 2024
| 4th UP Target | 435.24 |
| 3rd UP Target | 397.95 |
| 2nd UP Target | 374.89 |
| 1st UP Target | 351.84 |
| 1st DOWN Target | 286.06 |
| 2nd DOWN Target | 263.01 |
| 3rd DOWN Target | 239.95 |
| 4th DOWN Target | 202.66 |
GUFICBIO Weekly Target
| 4th UP Target | 336.82 |
| 3rd UP Target | 323.91 |
| 2nd UP Target | 315.92 |
| 1st UP Target | 307.94 |
| 1st DOWN Target | 285.16 |
| 2nd DOWN Target | 277.18 |
| 3rd DOWN Target | 269.19 |
| 4th DOWN Target | 256.28 |
GUFICBIO Target2024
| 4th UP Target | 645.2 |
| 3rd UP Target | 539.77 |
| 2nd UP Target | 474.6 |
| 1st UP Target | 409.43 |
| 1st DOWN Target | 223.47 |
| 2nd DOWN Target | 158.3 |
| 3rd DOWN Target | 93.13 |
| 4th DOWN Target | -12.3 |
Gufic Biosciences Limited ( NSE INDIA Symbol : GUFICBIO )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
GUFICBIO Synopsis Technicals View
| 50 Day EMA |
Close is Above EMA 50 (Short Term) |
Bullish | |
| 100 Day EMA | Close is Above EMA 100 (Mid Term) | Bullish | |
| 200 Day EMA | Close is Above EMA 200 (Long Term) | Bullish | |
| MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
| RSI (14) | RSI is Below 30 | Over Sold | |
| MFI (14) | MFI is 21.89 | Sideways | |
| CCI (20) | CCI is Below -100 | Over Sold | |
| WILLIAM %R (14) | William %R is Below -80 | Over Sold | |
| ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
| PSAR | Stoploss For Long Buy | 58.95 | |
| 10 Day Avg Volume | Traded 9.59 % More then 10 Day Average Volume | ||
GUFICBIO Other Details
| Segment | EQ | |
| Market Capital | 18264342528.00 | |
| Sector | Healthcare | |
| Industry | Drug Manufacturers-Specialty & Generic | |
| Offical website | > | |
GUFICBIO Address
 |
||
GUFICBIO Latest News
GUFICBIO Business Profile
Gufic Biosciences Limited engages in the research, development, manufacture, and marketing of active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India. It manufactures APIs and bulk drugs, such as antifungals, anesthetics, and intermediates for antifungals. The company also manufactures lyophilized injections, which include antibiotic, antifungal, cardiac, infertility, antiviral, and proton-pump inhibitor segments. In addition, it offers spark, criti care, aesthaderum, and ferticare pharmaceutical products; and herbal and personal care products. The company supplies its products to hospital chains and medical facilities. It also exports its products to countries across Asia, Africa, Latin American, and GCC markets. The company was founded in 1970 and is based in Mumbai, India. Address: SM House, Mumbai, India, 400057
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service